Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

Saved in:
Bibliographic Details
Published in:Radiotherapy and oncology 2024-01, Vol.190, p.109980
Main Authors: Mortensen, H.R., Populaire, P., Hoffmann, L., Moeller, D.S., Appelt, A., Nafteux, P., Muijs, C.T., Grau, C., Hawkins, M.A., Troost, E.G.C., Defraene, G., Canters, R., Clarke, C.S., Weber, D.C., Korevaar, E.W., Haustermans, K., Nordsmark, M., Gebski, Val, Achiam, M.P., Markar, Sheraz R., Radhakrishna, Ganesh, Berbee, Maaike, Scartoni, Daniele, Orlandi, Ester, Doyen, Jerome, Gregoire, Vincent, Crehange, Gilles, Langendijk, Johannes, Lorgelly, Paula, Blommestein, Hedwig M., Byskov, Camilla S., Ehmsen, Mai L., Jensen, Maria Fuglsang, Freixas, Gloria Vilches, Bütof, Rebecca
Format: Article
Language:English
Subjects:
Chemoradiotherapy
Esophageal Neoplasms - surgery
Esophagectomy
Humans
Neoadjuvant Therapy
Protons
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0167-8140
1879-0887
1879-0887
DOI:10.1016/j.radonc.2023.109980